Bipolar depression: An overview

IDrugs

Volumn 7, Issue 9, 2004, Pages 846-850

  Oral, E Timuçin ^a   Vahip, Simavi ^b  

^a Bakirkoy Women and Children Training and Research Hospital   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Bipolar depression; Cycle acceleration; Manic switch; Mood stabilizers; Novel antipyschotics; Prophylactic treatment

Indexed keywords

ARIPIPRAZOLE; CARBAMAZEPINE; CLOZAPINE; FLUOXETINE; IMIPRAMINE; LAMOTRIGINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OLANZAPINE; OMEGA 3 FATTY ACID; PAROXETINE; PLACEBO; PRAMIPEXOLE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; ZIPRASIDONE;

BIPOLAR DEPRESSION; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; DISEASE CLASSIFICATION; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG STRUCTURE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MONOTHERAPY; PHOTOTHERAPY; PSYCHOTHERAPY; REVIEW;

ACUTE DISEASE; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CHEMOPREVENTION; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM; TRIAZINES; VALPROIC ACID;

EID: 5044236652     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Keck PE Jr, McElroy SL, Arnold LM: Bipolar disorder. Med Clin North Am (2001) 85(3):645-661.
2. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP et al: Cross-national epidemiology of major depression and bipolar disorder. J Am Med Assoc (1996) 276(4):293-299.
3. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A: The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry (2003) 60(5):497-502.
4. Hirschfeld RM, Lewis L, Vornik LA: Perceptions and impact of bipolar disorder: How far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry (2003) 64(2):161-174.
5. Ghaemi SN, Boiman EE, Goodwin FK: Diagnosing bipolar disorder and the effect of antidepressants: A naturalistic study. J Clin Psychiatry (2000) 61(10):804-808.
6. Angst J, Sellaro R: Historical perspectives and natural history of bipolar disorder. Biol Psychiatry (2000) 48(6):445-457.
7. Benazzi F: Prevalence of bipolar II disorder in outpatient depression: A 203-case study in private practice. J Affect Disord (1997) 43(2):163-166.
8. Thase ME, Sachs GS: Bipolar depression: Pharmacotherapy and related therapeutic strategies. Biol Psychiatry (2000) 48(6):558-572.
9. Himmelhoch JM, Thase ME, Mallinger AG, Houck P: Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry (1991) 148(7):910-916.
10. Dunner DL, Fleiss JL, Fieve RR: The course of development of mania in patients with recurrent depression. Am J Psychiatry (1976) 133(8):905-908.
11. Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon M: Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors. J Affect Disord (1983) 5(2):115-128.
12. Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Keller M, Warshaw M, Clayton P, Goodwin F: Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry (1995) 52(2):114-123.
13. MacQueen GM, Young LT, Robb JC, Marriott M, Cooke RG, Joffe RT: Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder. Acta Psychiatr Scand (2000) 101(5):374-381.
14. Altshuler LL, Gitlin MJ, Mintz J, Leight KL, Frye MA: Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry (2002) 63(9):807-811.
15. Lester D: Suicidal behavior in bipolar and unipolar affective disorders: A meta-analysis. J Affect Disord (1993) 27(2):117-121.
16. Isometsa E, Heikkinen M, Henriksson M, Aro H, Lonnqvist J: Recent life events and completed suicide in bipolar affective disorder. A comparison with major depressive suicides. J Affect Disord (1995) 33(2):99-106.
17. Sharma V, Mazmanian D, Persad E, Kueneman K: A comparison of comorbid patterns in treatment-resistant unipolar and bipolar depression. Can J Psychiatry (1995) 40(5):270-274.
18. Vahip S: Koruyucu saǧaltimda yanitin belirlenebilirliǧi üzerine. [The predictibility of response in prophylactic treatment]. 3P Dergisi (2000) 8(Ek 2):19-22.
19. Ketter TA, Calabrese JR: Stabilization of mood from below versus above baseline in bipolar disorder: A new nomenclature. J Clin Psychiatry (2002) 63(2):146-151.
20. Herman E: Lamotrigine: A depressive mood stabiliser. 16th European College of Neuropsychopharmacology Congress, Prague, Czech Republic (2003).
21. Sachs GS, Koslow CL, Ghaemi SN: The treatment of bipolar depression. Bipolar Disord (2000) 2(3 Pt 2):256-260.
22. Keck PE Jr, Nelson EB, McElroy SL: Advances in the pharmacologic treatment of bipolar depression. Biol Psychiatry (2003) 53(8):671-679.
23. Zornberg GL, Pope HG Jr: Treatment of depression in bipolar disorder: New directions for research. J Clin Psychopharmacol (1993) 13(6):397-408.
24. Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD: Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry (2001) 158(6):906-912.
25. Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I: Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry (2000) 157(1):124-127.
26. Sachs G, Altshuler L, Ketter T, Suppes T, Rasgon N, Frye M, Collins M: Divalproex versus placebo for the treatment of bipolar depression. 40th Annual Meeting of the American College of Neuropsychopharmacology. San Juan, Puerto Rico (2001):Abs 51.
27. Keck PE Jr, McElroy SL: New approaches in managing bipolar depression. J Clin Psychiatry (2003) 64(Suppl 1):13-18.
28. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD: A double-blind, placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry (1999) 60(2):79-88.
29. Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, Luckenbaugh DA, Cora-Ocatelli G, Leverich GS, Post RM: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol (2000) 20(6):607-614.
30. Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M: Antidepressant-induced mania in bipolar patients: Identification of risk factors. J Clin Psychiatry (2001) 62(4):249-255.
31. Peet M: Induction of mania with selective serotonin reuptake inhibitors and tricyclic antidepressants. Br J Psychiatry (1994) 164(4):549-550.
32. Parker G, Paler K: Which antidepressants flick the switch? Aust NZ J Psychiatry (2003) 37(4):464-468.
33. Vahip S, Kandemir C, Akdeniz F, Gönül AS, Vahip I: Manic switch rates and possible risk factors: 5-Year retrospective evaluation from a university clinic. International Society for Bipolar Disorders Regional Group Conference, Sydney, Australia (2004):Abs 314.
34. Danish University Antidepressant Group: Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord (1990) 18(4):289-299.
35. Parker G: Differential effectiveness of the newer and older antidepressants mediated by an age effect on the phenotypic expression of depression? Acta Psychiatr Scand (2002) 106(3):168-170.
36. Altshuler L, Suppes T, Black D, Nolen WA, Keck PE Jr, Frye MA, McElroy S, Kupka R, Grunze H, Walden J, Leverich G et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 11-year follow-up. Am J Psychiatry (2003) 160(7):1252-1262.
37. Post RM, Altshuler LL, Frye MA, Suppes T, Rush AJ, Keck PE Jr, McElroy SL, Denicoff KD, Leverich GS, Kupka R, Nolen WA: Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disord (2001) 3(5):259-265.
38. Keck PE Jr, Mendlwicz J, Calabrese JR, Fawcett J, Suppes T, Vestergaard PA, Carbonell C: A review of randomized, controlled clinical trials in acute mania. J Affect Disord (2000) 59(Suppl 1):S31-S37.
39. Keck PE Jr, McElroy SL, Strakowski SM: Anticonvulsants and antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry (1998) 59(Suppl 6):74-81.
40. Tohen M, Vista E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry (2003) 60(11):1079-1088.
41. Goldberg JF, Burdick KE, Endick CJ: A placebo-controlled trial of pramipexole for bipolar depression. 155th Annual Meeting of the American Psychiatric Association, Philadelphia, PA, USA (2002):Abs 416.
42. Zaretsky A, Segal ZV, Gemar M: Cognitive therapy for bipolar depression: A pilot study. Can J Psychiatry (1999) 44(5):491-494.
43. Colom F, Vieta E, Martinez-Aran A, Reinares M, Goikolea JM, Benabarre A, Torrent C, Comes M, Corbella B, Parramon G, Corominas J: A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry (2003) 60(4):402-407.
44. Stoll AL, Severus WE, Freeman MP, Rueter S, Zyboyan HA, Diamond E, Cress KK, Marangell LB: Omega 3 fatty acids in bipolar disorder. A preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry (1999) 56(5):407-412.